基于靶向代谢组学的冠心病阵发性心房颤动痰浊证患者血清胆汁酸谱研究

褚瑜光; 柴若宁; 杨亦含; 袁果真

doi:10.16025/j.1674-1307.2022.10.006

您当前的位置：

首页 >

文章列表页 >

基于靶向代谢组学的冠心病阵发性心房颤动痰浊证患者血清胆汁酸谱研究

专题 | 更新时间：2023-06-16

- 基于靶向代谢组学的冠心病阵发性心房颤动痰浊证患者血清胆汁酸谱研究
- Study on serum bile acid profile of coronary heart disease combined with paroxysmal atrial fibrillation patients with stagnant phlegm syndrome based on targeted metabolomics
- 北京中医药 2022年41卷第10期页码：1102-1109
- 作者机构：
  
  1.中国中医科学院广安门医院心血管科，北京 100053
- 作者简介：
  
  袁果真，E-mail：guozhenyuan1316@126.com
- 基金信息：
  
  中央级公益性科研院所基本科研业务费专项(ZZ15-XY-LCQ-02);首都卫生发展科研专项(首发2022-1-4153);中国中医科学院科技创新工程项目(CI2021A00918)
- DOI：10.16025/j.1674-1307.2022.10.006
  中图分类号：
扫描看全文
褚瑜光，柴若宁，杨亦含，等.基于靶向代谢组学的冠心病阵发性心房颤动痰浊证患者血清胆汁酸谱研究［J］.北京中医药，2022，41（10）：1102-1109.

CHU Yu-guang,CHAI Ruo-ning,YANG Yi-Han,et al.Study on serum bile acid profile of coronary heart disease combined with paroxysmal atrial fibrillation patients with stagnant phlegm syndrome based on targeted metabolomics[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1102-1109.
褚瑜光，柴若宁，杨亦含，等.基于靶向代谢组学的冠心病阵发性心房颤动痰浊证患者血清胆汁酸谱研究［J］.北京中医药，2022，41（10）：1102-1109. DOI： 10.16025/j.1674-1307.2022.10.006.

CHU Yu-guang,CHAI Ruo-ning,YANG Yi-Han,et al.Study on serum bile acid profile of coronary heart disease combined with paroxysmal atrial fibrillation patients with stagnant phlegm syndrome based on targeted metabolomics[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1102-1109. DOI： 10.16025/j.1674-1307.2022.10.006.

摘要

目的,2,寻找冠心病阵发性心房颤动（CHD-PAF）心脾阳虚、痰浊内阻证（简称痰浊证）血清胆汁酸相关的潜在生物标志物。,方法,2,利用超高效液相色谱一三重四极杆质谱联用仪（UHPLC-MS/MS）技术检测CHD-PAF痰浊证和非痰浊证患者以及健康人的43种血清胆汁酸的浓度和含量，使用偏最小二乘方判别分析（PLS-DA）比较3组受试者的血清胆汁酸组代谢轮廓，使用相关性分析方法分析血清胆汁酸与CHD-PAF痰浊证患者的临床表型及证候发生的相关性，筛选CHD-PAF痰浊证的潜在胆汁酸生物标记物。,结果,2,CHD-PAF痰浊证患者的血清胆汁酸谱较非痰浊证患者发生显著变化，血清胆汁酸水平较非痰浊证患者显著升高，并与CHD-PAF痰浊证的发生存在相关性，其中以总胆汁酸、次级胆汁酸和游离胆汁酸的相关性最强。,结论,2,血清总胆汁酸、次级胆汁酸和游离胆汁酸升高可作为CHD-PAF心脾阳虚、痰浊内阻证临床辨证的潜在生物标记物。

Abstract

Objective,2,To explore the potential biomarkers related to serum bile acids for coronary heart disease combined with paroxysmal atrial fibrillation （CHD-PAF） patients with heart-spleen yang deficiency and stagnant phlegm syndrome.,Methods,2,The concentration and contents of 43 kinds of serum bile acids （BAs） in CHD-PAF patients with stagnant phlegm syndrome and non-stagnant phlegm syndrome and healthy population were detected by ultra-high performance liquid chromatography-mass spectrometry. Partial least square discriminant analysis （PLS-DA） was used to compare the metabolic profile of serum BAs among three test groups. Correlation analysis was used to analyze the correlation between serum BAs and the clinical phenotype， as well as BAs and occurrence of stagnant phlegm syndrome， and to screen the potential biomarkers related to serum BAs for CHD-PAF patients with stagnant phlegm syndrome.,Results,2,Compared with CHD-PAF patients with non-stagnant phlegm syndrome， the serum bile acid level was significantly higher than that of patients with non-stagnant phlegm syndrome， and it was correlated with the occurrence of CHD-PAF phlegm syndrome. With the strongest correlations being found for total， secondary and unconjugated BAs in particular.,Conclusion,2,Elevated serum total BAs， secondary BAs and unconjugated BAs can be used as potential biomarkers for the clinical pattern identification of CHD-PAF patients with heart-spleen yang deficiency and stagnant phlegm syndrome.

关键词

阵发性心房颤动冠心病痰浊证胆汁酸代谢组生物标志物

Keywords

Paroxysmal atrial fibrillationcoronary heart diseasestagnant phlegm syndromebile acid metabolomicsbiomarke

references

GOUDEVENOS JA, VAKALIS JN, GIOGIAKAS V, et al. An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece[J]. Europace,1999,1(4):226-233.

ZIMETBAUM P. Atrial fibrillation[J]. Ann Intern Med,2017,166(5):ITC33-ITC48.

HOHNLOSER SH, PAJITNEV D, POGUE J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy[J]. J Am Coll Cardiol,2007,50(22):2156-2161.

OLESEN JB, LIP GY, LANE DA, et al. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study[J]. Am J Med,2012,125(8):826.e13-23.

田鸿芳, 高树中, 马玉侠. 近十年中医证候的代谢组学研究进展[J]. 成都中医药大学学报,2013,36(2):99-102.

吕燕慧, 谢磊, 陈威,等. 代谢组学在中医证候中的应用进展[J]. 中国中药杂志,2022,47(2):367-375.

王莹, 芦瑞霞, 杨志旭. 基于文献检索的心房颤动中医病名、病因病机、证候研究[J]. 北京中医药,2021,40(6):660-663.

徐辰祺,卜军,何奔. 胆汁酸在心血管疾病中的作用[J]. 生理科学进展,2015,46（6）:424-428.

RAINER PP, PRIMESSNIG U, HARENKAMP S, et al. Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillation[J]. Heart,2013,99(22):1685-1692.

GEENES V, LöVGREN-SANDBLOM A, BENTHIN L, et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid[J]. PLoS One,2014,9(1):e83828.

KIRCHHOF P, BENUSSI S, KOTECHA D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962.

黄从新, 张澍, 黄德嘉,等. 心房颤动:目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志,2018,32(4):315-368.

KNUUTI J, WIJNS W, SARASTE A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.

CHACKO KA.AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart[J]. Circulation,1995,92(7):2003-2005.

郑筱萸. 中药新药临床研究指导原则（试行）[M]. 北京：中国医药科技出版社,2002.

中华人民共和国卫生部. 中药新药临床研究指导原则（第二辑）[M].北京：中国医药科技出版社,1995.

朱文锋. 中医诊断学[M]. 北京：中国中医药出版社, 2010.

朱文锋. 证素辨证学[M]. 北京：人民卫生出版社，2008.

贾增芹, 鲁喦, 李涛,等. 新药Ⅰ期临床试验健康受试者筛选案例分析:实验室指标纳入标准探讨[J]. 中国新药杂志,2012,21(2):156-160.

WARNER R. Applied statistics: From bivariate through multivariate techniques[M]. Los Angeles: Sage Publications,2012:317.

YOSHIMOTO S, LOO TM, ATARASHI K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J]. Nature,2013,499(7456):97-101.

窦莉莉, 杨帆. 某区慢性肾功能衰竭患者中医体质构成的研究分析[J]. 中国医药指南,2016,14(10):186-187.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

芪葶利水方对冠心病心力衰竭患者临床疗效、生活质量及血清基质金属蛋白酶的影响